Using MMP-3 and Inflammatory Markers to Detect Osteoarthritis Early

Osteoarthritis is often thought of as a “wear and tear” condition.

But the reality is far more complex.

It is a biologic process that begins years—sometimes decades—before symptoms appear.

The Role of MMP-3 blood test

MMP-3 is an enzyme involved in the breakdown of cartilage and extracellular matrix.

Elevated levels indicate increased tissue degradation—even in the absence of pain.

This makes MMP-3 a powerful early warning signal.

A Proactive Approach

By combining MMP-3 with other markers such as:

• C-reactive protein (CRP)

• Erythrocyte sedimentation rate (ESR)

• Cytokine profiles

We can identify patients at risk for joint degeneration before structural damage occurs.

Early Intervention Changes Outcomes

When detected early, interventions may include:

• Anti-inflammatory strategies

• Peptide therapy

• Biologic injections

• Movement optimization

Integrating Imaging

Ultrasound allows us to correlate biomarker data with:

• Tissue structure

• Early degeneration

• Functional abnormalities

The Shift in Orthopedics

Traditional care waits for damage.

Regenerative medicine anticipates it.

At RegeneZone, we focus on:

• Early detection

• Targeted intervention

• Long-term preservation

Because the best way to treat osteoarthritis is to stop it before it starts.